文献速递外周动脉疾病

用于血管评估的近即时无创光学成像检测组织灌注

Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment.
PubMed 文献 · J Vasc Surg · 2018-10-03

本研究前瞻性纳入47例疑诊外周动脉疾病(PAD)的连续患者,评估空间频域成像(SFDI)在10秒内无接触测量足底组织氧饱和度(StO2)和组织血红蛋白的能力。SFDI的StO2可区分无糖尿病患者的动脉疾病(踝肱指数<0.9,P=.06),但在糖尿病患者中受限(P=.43);SFDI衍生的HbT2/HbT1指数以趾肱指数<0.7为PAD cutoff可区分糖尿病合并与不合并PAD者(P<.01)。

要点

  • SFDI可在10秒内无接触获取足底StO2及组织血红蛋白。
  • 无糖尿病者StO2区分ABI<0.9的动脉疾病P=.06,糖尿病者P=.43。
  • HbT2/HbT1指数以TBI<0.7为cutoff可区分糖尿病PAD(P<.01)。

核心结论

  • SFDI是临床环境中可行、快速且易用的宽场灌注测量方法,首次使用研究提示该技术有潜力评估有无糖尿病者的下肢灌注。
  • 需要设计纳入更多患者并以伤口愈合为终点之一的进一步研究,以充分评估该新技术的适用性。

研究设计与样本

  • 前瞻性评估47例连续患者的踝肱指数、趾肱指数、足部多普勒波形和SFDI图像,患者有无糖尿病均可且有外周动脉疾病(PAD)疑虑。
  • SFDI是一种非接触光学成像技术,利用结构光照明在10秒内量化大片视野(15×20 cm)内真皮微循环(HbT1)和大循环(HbT2)的皮下(深度2-3 mm)StO2和组织血红蛋白。

主要发现

  • SFDI能够捕获足底可靠临床灌注测量值。
  • SFDI的StO2值可区分无糖尿病者有无动脉疾病(定义为踝肱指数<0.9,P=.06),但在糖尿病患者中受限(P=.43)。
  • 与无糖尿病患者相比,糖尿病患者观察到StO2升高和HbT1降低(P<.05)。
  • SFDI衍生的HbT2/HbT1指数以趾肱指数<0.7作为糖尿病PAD cutoff,可区分糖尿病合并PAD与不合并PAD者(P<.01)。

关键数值与推荐

  • 动脉疾病定义为踝肱指数<0.9,无糖尿病者StO2区分有无动脉疾病P=.06。
  • 糖尿病者StO2区分有无动脉疾病P=.43。
  • 糖尿病合并PAD与不合并PAD的区分采用趾肱指数<0.7作为cutoff,HbT2/HbT1指数P<.01。

临床怎么用

  • SFDI是临床环境中可行、快速且易用的宽场灌注测量方法,首次使用研究提示该技术有潜力评估有无糖尿病者的下肢灌注。
  • 作者建议需要设计纳入更多患者并以伤口愈合为终点之一的进一步研究,以充分评估该新技术的适用性。

局限性

  • SFDI的StO2值在糖尿病患者中区分有无动脉疾病受限(P=.43)。
  • 首次使用研究,需要设计纳入更多患者并以伤口愈合为终点之一的进一步研究,以充分评估该新技术的适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Noninvasive vascular tests are critical for identifying patients who may benefit from surgical revascularization, but current tests have significant limitations in people with diabetes. This study aimed to evaluate the ability of spatial frequency domain imaging (SFDI), an optical imaging method capable of measuring tissue oxygen saturation (StO2) and tissue hemoglobin, to assess lower extremity blood supply. METHODS: Ankle-brachial index, toe-brachial index, pedal Doppler waveforms, and SFDI images were prospectively evaluated in 47 consecutive patients with and without diabetes in whom there was concern for peripheral artery disease (PAD). SFDI is a noncontact optical imaging technology that uses structured illumination to quantify subsurface (2-3 mm in depth) StO2 and tissue hemoglobin in the dermal microcirculation (HbT1) and macrocirculation (HbT2) over a large field of view (15 × 20 cm) within 10 seconds. RESULTS: This demonstrates the ability of SFDI to capture reliable clinical measurements of perfusion in plantar aspects of the feet. SFDI StO2 values differentiate nondiabetic patients with and without arterial disease, defined as ankle-brachial index <0.9 (P = .06), but are limited in those with diabetes (P = .43). An elevated StO2 and reduced HbT1 are observed in people with diabetes compared with nondiabetic patients (P < .05). An SFDI-derived HbT2/HbT1 index differentiates diabetics with PAD vs no PAD (P < .01) using toe-brachial index <0.7 as a cutoff for PAD in diabetes. CONCLUSIONS: SFDI is a feasible, rapid, and easy to use widefield measurement of perfusion in a clinical setting. This first-of-use study suggests that the technology has potential to evaluate lower extremity perfusion in people with and without diabetes. Further studies with increased numbers of patients and end points including wound healing will need to be designed to fully evaluate the applicability of this new technology.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Weinkauf C, Mazhar A, Vaishnav K, et al. Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment. J Vasc Surg. 2018. PMID: 30292608. doi:10.1016/j.jvs.2018.06.202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。